Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+46.3%
5Y CAGR+173.0%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+46.3%/yr
Annual compound
5Y CAGR
+173.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
151.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202543.76+212.1%
202414.02-41.0%
202323.76+69.9%
202213.98+535.5%
20212.20+663.0%
20200.29-